



Our tests will guide you and your health care providers in choosing the right treatment plan
We provide you with all the information you require for the best treatment options.
Our tests are designed in such way to understand the various aspects of cancer and helps the doctors in creating the accurate treatment plan
-
Onconomics RGCC Test
This test includes the chemosensitivity / chemoresistance assessment for cytotoxic drugs.
See More >
-
Onconomics Extracts Test
This test includes only the assessment of natural substances and plant extracts for any anticancer potency.
See More >
-
Onconomics Plus RGCC Test
This provides information on the sensitivity or resistance of the patient's tumour cells to certain cancer drugs and shows options for targeted therapy or an alternative treatment method with organic substances.
See More >
-
Oncocount RGCC Test
This test will report only the number of Circulating Cancer Tumor Cells (CTC's). It does.
See More
-
Oncotrace RGCC Test
This test will report the number of CTC's, any positive CSC's, and the immunophenotype of these cells.
See More >
-
Oncotrail RGCC Test
This test is a tailor made test for a specific type of malignancy such as breast cancer.
See More >
-
Immune Frame Test
Profile of humoral and cellular immunity and cachexia. This test uses specific cellular markers.
See More >
-
Metastat RGCC Test
Markers on CTCs that point out the potential organ for relapse. It can help practitioners.
See More >
-
aCGH Test
The array comparative genomic hybridisation (aCGH) test is used to identify abnormalities in a genome,when either part of the genetic sequence in a chromosome is deleted or added to – that might lead to cancer.
See More >
-
RGCC CAMBISEQ™
RGCC cancer analysis, mutational burden and instability sequencing (CAMBISeq) provides next- generation sequencing analysis on both DNA and RNA. RGCC CAMBISeq can help to identify variants in more than 500 genes,
See More >

RGCC CAMBISEQ™
RGCC cancer analysis, mutational burden and instability sequencing (CAMBISeq) provides next- generation sequencing analysis on both DNA and RNA. RGCC CAMBISeq can help to identify variants in more than 500 genes,
See more >
aCGH Test
The array comparative genomic hybridisation (aCGH) test is used to identify abnormalities in a genome,when either part of the genetic sequence in a chromosome is deleted or added to – that might lead to cancer.
See more >
Metastat RGCC Test
Markers on CTCs that point out the potential organ for relapse. It can help practitioners in the prognosis of metastases trends in cancer patients.
See more >
Immune Frame Test
Profile of humoral and cellular immunity and cachexia. This test uses specific cellular markers and cytokine production to detect the type/types of cells that are responsible for activation / repression of the immune system of host.
See more >
Oncotrail RGCC Test
This test is a tailor made test for a specific type of malignancy such as breast cancer (Oncotrail for Breast), prostate (Oncotrail for Prostate), Colon, Melanoma, Lung, Sarcoma, Gastrointestinal for follow up control.
See more >
Oncotrace RGCC Test
This test will report the number of CTC's, any positive CSC's, and the immunophenotype of these cells.
See more >
Oncocount RGCC Test
This test will report only the number of Circulating Cancer Tumor Cells (CTC's). It does not include any other information concerning the CTC's or Circulating Cancer Stem Cells (CSC's) Immunophenotyping.
See more >
Onconomics Plus RGCC Test
4. This test is the combination of both Onconomics and Onconomics extracts test, which includes conventional treatment information, Gene profiling and the Integrative Treatment information.
See more >
Onconomics Extracts Test
This test includes only the assessment of natural substances and plant extracts for any anticancer potency. No chemotherapeutic agents tested and no tumor suppressor genes tested.
See more >
Onconomics RGCC Test
The test includes the chemosensitivity / chemoresistance assessment for cytotoxic drugs, monoclonal antibodies, and small molecules that inhibit specific targets eg.(TKI's) and Gene profiling at Epigenetic level. No Natural substances are tested.
See more >tests so you can choose the best treatment.
What Our Doctor's Say:

Using this test helps oncologists take the possible drug out of chemo selection, increasing the likelihood of successful treatment, and reducing unnecessary toxic side effects by avoiding chemos that would not work
Ctcs can play a key role in improving metastatic breast cancer treatment1
Ctcs can play a key role in improving metastatic breast cancer treatment

NEELI GENETIC SERVICES
Call us: +(91) 789-356-2434, +(91) 770-208-4807, +(91) 789-356-2434 (whatsapp)
Email: Office@neeligenetics.com